Share

September 2022; 9 (5) Research ArticleOpen Access

IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy

Alexandre Jentzer, Arthur Attal, Clémence Roué, Julie Raymond, Cinta Lleixà, Isabel Illa, Luis Querol, Guillaume Taieb, Jérôme Devaux
First published August 10, 2022, DOI: https://doi.org/10.1212/NXI.0000000000200014
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
324

Share

Article Information

vol. 9 no. 5 e200014
DOI: 
https://doi.org/10.1212/NXI.0000000000200014
PubMed: 
35948442
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received February 10, 2022
  • Accepted in final form May 18, 2022
  • First Published August 10, 2022.
Copyright & Usage: 
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Alexandre Jentzer, MD, PhD*,
    2. Arthur Attal, MD*,
    3. Clémence Roué, MS,
    4. Julie Raymond, MS,
    5. Cinta Lleixà, MD, PhD,
    6. Isabel Illa, MD, PhD,
    7. Luis Querol, MD, PhD,
    8. Guillaume Taieb, MD, PhD and
    9. Jérôme Devaux, PhD
    10. on behalf of the anti–neurofascin-155 study group
  1. Alexandre Jentzer, MD, PhD*,
  2. Arthur Attal, MD*,
  3. Clémence Roué, MS,
  4. Julie Raymond, MS,
  5. Cinta Lleixà, MD, PhD,
  6. Isabel Illa, MD, PhD,
  7. Luis Querol, MD, PhD,
  8. Guillaume Taieb, MD, PhD and
  9. Jérôme Devaux, PhD
  1. From the Institute for Neurosciences of Montpellier (A.J., A.A., G.T., J.D.), INSERM U1051, Montpellier University, Hôpital Saint Eloi, France; Department of Immunology (A.J.), CHU Montpellier, France ; Department of Neurology (A.A., G.T.), CHU Montpellier, Hôpital Gui de Chauliac, France; Institut de Génomique Fonctionnelle (C.R., J.R., G.T., J.D.), CNRS UMR5203, France; and Neuromuscular Diseases Unit (C.L., I.I., L.Q.), Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Spain.
  1. Correspondence
    Dr. Devaux jerome.devaux{at}inserm.fr
View Full Text

Article usage

Article usage: August 2022 to December 2022

AbstractFullPdfSource
Aug 202212672150Highwire
Sep 20221827879Highwire
Oct 2022819242Highwire
Nov 2022922839Highwire
Dec 202223314Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me